2nd International Conference on Hematology and Oncology
August 23-24, 2018 | London, UK
Keynote
-
Evaluation of classical and novel von Willebrand Factor assays in ECLM defined von Willebrand disease patients
Hematol Blood Disord
Jan Michiels -
Hematopoietic cell transplantation for myelodysplastic syndrome and myeloproliferative neoplasms: issues of age, ethics, and uncertainty
Hematol Blood Disord
H Joachim Deeg